Michael R. McMullen - Nov 16, 2021 Form 4 Insider Report for AGILENT TECHNOLOGIES, INC. (A)

Role
CEO and President, Director
Signature
/s/ P. Diana Chiu, attorney-in-fact for Mr. McMullen
Stock symbol
A
Transactions as of
Nov 16, 2021
Transactions value $
$22,478,561
Form type
4
Date filed
11/18/2021, 08:24 PM
Previous filing
Nov 16, 2021
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction A Common Stock Award $2.62M +16.2K +6.55% $161.39 264K Nov 16, 2021 Direct F1
transaction A Common Stock Award $22M +136K +51.5% $161.39 400K Nov 16, 2021 Direct F2
transaction A Common Stock Tax liability -$12.2M -75.5K -18.86% $161.39 325K Nov 16, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction A Employee Stock Option (Right to Buy) Award $10.1M +62.5K $161.39 62.5K Nov 16, 2021 Common Stock 62.5K $161.39 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 16, 2022 and are subject to a 1 year post-vest holding period.
F2 On November 16, 2021, 136,087 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1 year post-vest holding period.
F3 The reporting person surrendered 75,497 shares to Agilent to satisfy tax liability on the release of restricted shares in accordance with Rule 16b-3.
F4 Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3.
F5 The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.